Patient engagement in Ontario's drug reimbursement decision making process: 2 years post Bill 102

Published: Nov 21, 2009
Terms: Articles, Bill 102, Event, Patient engagement, Canada

Patient engagement in Ontario's drug reimbursement decision making process: 2 years post Bill 102

Wednesday November 12 2008 to Wednesday November 12 2008
Hosting Organizations: Rx&D's Ontario Stakeholder/Industry Committee
Contact: Steven Lott
Website:


This breakfast panel discussion will examine at how Bill 102 has impacted the engagement of patients in the decision making process from all sides of the equation.

Panel members include:

  • Helen Stevenson, Executive Officer, Ontario Public Drug Program, MOHLTC
  • Harlon Davey, Patient Representative, Committee to Evaluate Drugs
  • Karen Philip, Patient Group Representative, Pharmacy Council
  • Elisabeth Fowler, World Health Advocacy
Event Home
Written by:

Share this article